Page last updated: 2024-08-22

limonene and Breast Neoplasms

limonene has been researched along with Breast Neoplasms in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (40.00)18.2507
2000's1 (6.67)29.6817
2010's4 (26.67)24.3611
2020's4 (26.67)2.80

Authors

AuthorsStudies
Mandal, D; Parija, T; Patel, P; Sahu, BR; Verma, SK1
Mandal, D; Parija, T; Sahu, BR1
Alipanah, H; Farjam, M; Osanloo, M; Roozitalab, G; Zarenezhad, E1
Chebet, JJ; Ehiri, JE; Hakim, IA; McClelland, DJ; Taren, D1
Câmara, JS; Capelinha, F; Perestrelo, R; Silva, C; Silva, P; Tomás, H1
Chow, HH; Cordova, C; Hsu, CH; Lang, JE; Ley, M; Miller, JA; Nagle, R; Thompson, PA; Waer, A1
Chow, HH; Hu, C; Keun, HC; Lang, JE; Miller, JA; Pappan, K; Siskos, AP; Thompson, PA; Want, EJ; Wulff, J1
Anthony, JR; Gupta, S; Marko, MG; Miller, VA; Porter, JR; Schaefer, FT1
el-Bayoumy, K1
O'Shaughnessy, JA1
Coombes, RC; Griggs, LJ; Jarman, M; Poon, GK; Rowlands, MG; Vigushin, D1
Burke, YD; Crowell, PL; Siar Ayoubi, A1
Miller, AC; Samid, D1
Bardon, S; Martel, P; Picard, K1
Bradlow, HL; Sepkovic, DW1

Reviews

3 review(s) available for limonene and Breast Neoplasms

ArticleYear
Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis.
    BMC cancer, 2021, Aug-06, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Combined Modality Therapy; Drug Monitoring; Female; Humans; Limonene; Maximum Tolerated Dose; Middle Aged; Molecular Structure; Treatment Outcome

2021
Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials.
    Carcinogenesis, 1994, Volume: 15, Issue:11

    Topics: Animals; Anticarcinogenic Agents; Arachidonic Acid; Breast Neoplasms; Caffeine; Cyclohexenes; Female; Humans; Limonene; Mammary Neoplasms, Experimental; Mice; Rats; Retinoids; Selenium; Terpenes; Vitamin E

1994
Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer.
    Advances in experimental medicine and biology, 1996, Volume: 401

    Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Breast Neoplasms; Cyclohexenes; Dietary Fats, Unsaturated; Drug Screening Assays, Antitumor; Humans; Limonene; Monoterpenes; Pancreatic Neoplasms; Terpenes

1996

Trials

2 trial(s) available for limonene and Breast Neoplasms

ArticleYear
Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:6

    Topics: Anticarcinogenic Agents; Biomarkers, Tumor; Breast; Breast Neoplasms; Caspase 3; Citrus; Cyclin D1; Cyclohexenes; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Interleukin-6; Limonene; Middle Aged; Monoterpenes; Neoplasm Staging; Pilot Projects; Prognosis; Terpenes; Tissue Distribution; Transforming Growth Factor beta1

2013
Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometry.
    Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:5

    Topics: Adult; Aged; Alkyl and Aryl Transferases; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chromatography, Liquid; Colorectal Neoplasms; Cyclohexenes; Farnesyltranstransferase; Female; Humans; Limonene; Male; Mass Spectrometry; Middle Aged; Molecular Structure; Terpenes; Transferases

1996

Other Studies

10 other study(ies) available for limonene and Breast Neoplasms

ArticleYear
Proximal discrepancy in intrinsic atomic interaction arrests G2/M phase by inhibiting Cyclin B1/CDK1 to infer molecular and cellular biocompatibility of D-limonene.
    Scientific reports, 2022, 10-28, Volume: 12, Issue:1

    Topics: Apoptosis; Breast Neoplasms; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Female; Humans; Limonene; Mitosis; Molecular Docking Simulation

2022
Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells.
    Medical oncology (Northwood, London, England), 2023, Jun-30, Volume: 40, Issue:8

    Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Female; Humans; Limonene; Tamoxifen

2023
Chitosan nanoparticles containing limonene and limonene-rich essential oils: potential phytotherapy agents for the treatment of melanoma and breast cancers.
    BMC complementary medicine and therapies, 2021, Jul-02, Volume: 21, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Citrus; Drug Delivery Systems; Female; Humans; Limonene; Melanoma; Nanoparticles; Phytotherapy

2021
Volatomic pattern of breast cancer and cancer-free tissues as a powerful strategy to identify potential biomarkers.
    The Analyst, 2019, Jul-21, Volume: 144, Issue:14

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Decanoic Acids; Female; Furaldehyde; Gas Chromatography-Mass Spectrometry; Humans; Limonene; Metabolomics; Middle Aged; Multivariate Analysis; ROC Curve; Volatile Organic Compounds

2019
Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.
    Cancer prevention research (Philadelphia, Pa.), 2015, Volume: 8, Issue:1

    Topics: Amino Acids; Anticarcinogenic Agents; Antineoplastic Agents; Bile Acids and Salts; Breast Neoplasms; Carnitine; Cell Cycle; Collagen; Cyclin D1; Cyclohexenes; Female; Gas Chromatography-Mass Spectrometry; Glucose; Humans; Limonene; Metabolome; Metabolomics; Plasma; Terpenes

2015
Novel production of terpenoids in Escherichia coli and activities against breast cancer cell lines.
    Applied biochemistry and biotechnology, 2015, Volume: 175, Issue:5

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclohexenes; Escherichia coli; Female; Hemiterpenes; Humans; Limonene; Metabolic Engineering; Organophosphorus Compounds; Terpenes

2015
Chemoprevention of breast cancer.
    JAMA, 1996, May-01, Volume: 275, Issue:17

    Topics: Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Clinical Trials as Topic; Combined Modality Therapy; Cyclohexenes; Dehydroepiandrosterone; Estrogen Antagonists; Female; Genistein; Humans; Isoflavones; Limonene; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Retinoids; Tamoxifen; Terpenes

1996
Tumor radiosensitization based on the use of inhibitors of the mevalonate pathway of cholesterol synthesis.
    Advances in experimental medicine and biology, 1997, Volume: 400B

    Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Cell Survival; Cholesterol; Cobalt Radioisotopes; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cyclohexenes; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Gamma Rays; Genes, ras; Glioblastoma; Humans; Limonene; Lung Neoplasms; Male; Mevalonic Acid; Prostatic Neoplasms; Radiation-Sensitizing Agents; Terpenes; Tumor Cells, Cultured

1997
Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines.
    Nutrition and cancer, 1998, Volume: 32, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclohexenes; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Limonene; Monoterpenes; Terpenes; Tumor Cells, Cultured

1998
Diet and breast cancer.
    Annals of the New York Academy of Sciences, 2002, Volume: 963

    Topics: Animals; Breast Neoplasms; Catechin; Cattle; Coumaric Acids; Cyclohexenes; Dehydroepiandrosterone; Diet; Female; Genistein; Humans; Indoles; Isothiocyanates; Limonene; Milk; Terpenes

2002